Current price places the company's stock 1.38% away from its 200-day simple moving average, 6.39%, away from the 50-day average and also 5.84% away from 20-day average.
Analysts are expecting average earnings estimates of $0.03 for the current quarter based on the opinion of 1 analysts, relating to high earnings per share estimates of $0.03 and low estimates of $0.03, however Cousins Properties Inc (NYSE:CUZ) reported $0.01 earnings per share for the same quarter a year ago. CUZ underperformed the S&P500 by 6.08%. Shares are trading price at $9.12 with move of 0.55%. Benchmark Electronics Inc. now has $1.27 billion valuation. The stock decreased 2.67% or $1.505 during the last trading session, reaching $54.805. About 250,947 shares traded. The Madison Square Garden Company (NYSE:MSG) has risen 23.03% since May 3, 2017 and is uptrending. It has underperformed by 14.93% the S&P500. The positive are 75%. Advantus Cap Incorporated reported 0.01% of its portfolio in Cousins Properties Incorporated (NYSE:CUZ). $10.33's average target is 16.33% above currents $8.88 stock price. Since December 4, 2017 according to StockzIntelligence Inc Cousins Properties has 4 analyst reports. Finally, ValuEngine cut shares of Cousins Properties from a "buy" rating to a "hold" rating in a report on Friday, February 2nd. Blackrock holds 0.03% of its capital in Cousins Properties Incorporated (NYSE:CUZ) for 57.13M shs. The rating was downgraded by Robert W. Baird to "Neutral" on Wednesday, August 17. A broker rating of 1 would translate into a Strong Buy. 117 institutional investors opened new and increased stock positions, while 85 sold and decreased equity positions in Cousins Properties Inc so the sentiment is negative. The stock of CVS Health Corporation (NYSE:CVS) earned "Neutral" rating by Citigroup on Tuesday, February 13. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company's stock. On Monday, December 4 the company was upgraded by Bank of America. The firm has "Sell" rating given on Thursday, September 29 by Stifel Nicolaus. Capital One also issued estimates for Cousins Properties' Q2 2019 earnings at $0.17 EPS, Q3 2019 earnings at $0.17 EPS, Q4 2019 earnings at $0.17 EPS and FY2019 earnings at $0.67 EPS. The stock has a consensus rating of "Buy" and an average target price of $10.10.
Big Money Sentiment decreased to 1.38 in Q4 2017. Shortening the period, the five-month price index is 0.98, the three-month price index is 1.03, while the one-month price change is now 1.06. Cousins Properties's dividend payout ratio (DPR) is 42.62%. 449.90 million shares or 1.91% more from 441.47 million shares in 2017Q3 were reported. State Board Of Administration Of Florida Retirement System has 166,493 shares for 0% of their portfolio. Ellington Mgmt Gp Limited Liability accumulated 0.14% or 91,600 shares. Investors of record on Tuesday, April 3rd were given a $0.065 dividend. Renaissance Ltd holds 2.10M shs.
Yaya Toure to leave Man City, says Guardiola
They will then ensure Toure is given a fitting send-off after their final home game against Brighton next Wednesday. As iF that weren't enough, two more goals would take City past Chelsea's record tally of 102 from 2009/10.
Several large investors have recently bought and sold shares of CUZ. The difference between the actual and expected EPS is $0.23 a share with a surprise factor of 104.5%. California State Teachers Retirement System owns 78,848 shares or 0% of their USA portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) owns 36,061 shares. Wells Fargo And Mn reported 1.35M shs. Koch reported 27,151 shares. Landscape Mngmt Limited Liability Corp holds 178,300 shares or 0.15% of its portfolio. North Point Portfolio Managers Corp Oh owns 5,166 shares. Rhumbline Advisers stated it has 922,558 shares. Great Lakes Advsr Ltd Company has 0.12% invested in Cousins Properties Incorporated (NYSE:CUZ). Cousins Properties Inc (NYSE:CUZ)'s price to free cash flow for trailing twelve months is 0.
Since December 12, 2017, it had 0 insider buys, and 1 insider sale for $699,784 activity. "Buy" rating has 3, "Sell" are 0, while 1 are "Hold". CVS Health had 76 analyst reports since July 22, 2015 according to SRatingsIntel. Robert W. Baird upgraded the stock to "Outperform" rating in Thursday, January 7 report. Technical analysts believe that volume can serve as a warning signal as to whether a stock is on the verge of breaking into upside territory (high volume) or into a downside trend (low volume). The firm has "Buy" rating given on Monday, November 7 by GMP Securities.